Symmetry-guided fusion converts weak liver pyruvate kinase inhibitors into potent allosteric activators
Structure-guided exploitation of symmetry within multimeric protein interfaces offers an opportunity to convert partial ligand-binding poses into higher-affinity modulators. Here, we report a class of symmetrical "Z-shaped" allosteric activators of human liver pyruvate kinase (PKL), generated by symmetry-guided fusion of binding poses identified in inhibitor-bound crystal structures. The resulting ligands span the inter-subunit pocket at the tetrameric dimer-dimer interface and display substantially enhanced activity, with several analogues showing nanomolar activation potency. In HepG2 PKM2-knockout cells, the compounds increased PKL activity, maximal mitochondrial respiratory capacity and glycolytic proton efflux without altering PKL expression, Ser113 phosphorylation-dependent localisation, cell proliferation or triglyceride accumulation under the conditions examined. These findings establish symmetry-guided ligand fusion as a productive design strategy in this PKL system and provide structurally defined chemical tools for investigating the metabolic consequences of direct PKL activation.
Authors
- Aleksei Lulla (ORCID: https://orcid.org/0000-0001-5410-1921)
- Leticia Monjas (ORCID: https://orcid.org/0000-0003-0624-9934)
- Liliana Håversen (ORCID: https://orcid.org/0000-0001-5180-7830)
- Adil Mardinoğlu (ORCID: https://orcid.org/0000-0002-4254-6090)
- Oscar Nilsson (ORCID: https://orcid.org/0000-0003-2716-2563)
- Jan Borén (ORCID: https://orcid.org/0000-0003-0786-8091)
- Mikael Rutberg
- Marko Hyvönen (ORCID: https://orcid.org/0000-0001-8683-4070)
- P. Brear (ORCID: https://orcid.org/0000-0002-4045-0474)
- Anders Foller Füchtbauer (ORCID: https://orcid.org/0000-0003-0223-5754)
- Morten Grøtli (ORCID: https://orcid.org/0000-0003-3621-4222)
- Per-Olof Bergh
- Alexandra Rodriguez-Rivero
Institutions
- University of Cambridge (GB)
- Science for Life Laboratory (SE)
- Sahlgrenska University Hospital (SE)
- KTH Royal Institute of Technology (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- RSC Medicinal Chemistry
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6md00604c
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Torsten Söderbergs Stiftelse
- Diamond Light Source
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Novo Nordisk Fonden
- Department of Biochemistry, University of Cambridge